Both in Biotechnology
Monte Rosa Therapeutics vs Attovia Therapeutics
Over the past year GLUE returned −26.0% and ATTO returned −33.0%; their daily moves had a correlation of 0.16.
GLUE −26.0% ATTO −33.0%Growth of $1, one year, split-adjusted
| Metric | GLUE | ATTO |
|---|---|---|
| Price | $10.41 | $15.27 |
| Market cap | $888.1M | $697.1M |
| Today | −2.07% | +1.46% |
| 1 month | +1.4% | −15.1% |
| 6 months | −46.2% | — |
| Year to date | −33.6% | — |
| 1 year | −19.0% | — |
| Revenue growth (YoY) | −61.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −483.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 30.9× | — |
| Net cash | $621.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | — |
| Short % of float | 41.9% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).